Olin (NYSE:OLN – Get Free Report) posted its quarterly earnings results on Thursday. The specialty chemicals company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.08 by ($0.20), FiscalAI reports. The company had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.81 billion. Olin had a negative return on equity of 4.68% and a negative net margin of 1.89%.Olin’s revenue was down .9% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.01) earnings per share.
Olin Trading Down 0.4%
Shares of OLN traded down $0.08 during mid-day trading on Thursday, hitting $22.11. 2,578,224 shares of the company’s stock traded hands, compared to its average volume of 2,854,892. The company has a quick ratio of 0.82, a current ratio of 1.36 and a debt-to-equity ratio of 1.73. Olin has a 1 year low of $18.08 and a 1 year high of $30.46. The firm has a market capitalization of $2.52 billion, a P/E ratio of -19.74 and a beta of 1.21. The business’s 50-day moving average price is $22.87 and its 200-day moving average price is $24.79.
Institutional Trading of Olin
Several large investors have recently added to or reduced their stakes in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new position in Olin during the 1st quarter valued at $32,000. UMB Bank n.a. boosted its stake in shares of Olin by 34.0% during the 4th quarter. UMB Bank n.a. now owns 2,597 shares of the specialty chemicals company’s stock valued at $54,000 after purchasing an additional 659 shares in the last quarter. NewEdge Advisors LLC increased its position in shares of Olin by 45.0% during the third quarter. NewEdge Advisors LLC now owns 2,323 shares of the specialty chemicals company’s stock valued at $58,000 after buying an additional 721 shares during the period. Headlands Technologies LLC increased its position in shares of Olin by 67.6% during the second quarter. Headlands Technologies LLC now owns 4,400 shares of the specialty chemicals company’s stock valued at $88,000 after buying an additional 1,775 shares during the period. Finally, Tower Research Capital LLC TRC raised its stake in Olin by 20.5% in the second quarter. Tower Research Capital LLC TRC now owns 7,031 shares of the specialty chemicals company’s stock worth $141,000 after buying an additional 1,195 shares in the last quarter. Institutional investors own 88.67% of the company’s stock.
Wall Street Analyst Weigh In
View Our Latest Analysis on OLN
Olin Company Profile
Olin Corporation is a diversified manufacturer specializing in chemical products and ammunition. The company’s core business activities encompass the production and distribution of chlor-alkali products, epoxy resins and derivatives, and small-caliber ammunition under the Winchester brand. Olin’s chemical operations supply chlorine, caustic soda and related co-products to a wide range of end markets, including water treatment, pulp and paper, pharmaceuticals and general industrial applications.
In its Chlor Alkali Products & Vinyls segment, Olin operates multiple manufacturing facilities that produce chlorine and sodium hydroxide, along with vinyl chloride monomer and polyvinyl chloride (PVC) compounds.
Recommended Stories
- Five stocks we like better than Olin
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for Olin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olin and related companies with MarketBeat.com's FREE daily email newsletter.
